Originally published by our sister publication, Pain Medicine News
The American College of Rheumatology (ACR) released new updated guidelines for the treatment and management of juvenile idiopathic arthritis (JIA): one on the pharmacologic treatment of oligoarthritis, temporomandibular arthritis and systemic JIA, and another on nonpharmacologic therapies, medication monitoring, immunizations and imaging, regardless of JIA phenotype.
The original JIA guidelines were published in 2011 and 2013, and